Condensed Consolidated Statements of Operations (unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Operating expense:
Research & development	$ 2,796,214	$ 1,098,617	$ 8,330,727	$ 3,163,179
General & administrative	5,265,965	1,255,466	17,156,952	2,147,635
Total operating expenses	8,062,179	2,354,083	25,487,679	5,310,814
Operating loss	(8,062,179)	(2,354,083)	(25,487,679)	(5,310,814)
Other income, net
Interest income, net	(92,094)		(317,307)
Total other income, net	(92,094)		(317,307)
Net Loss	$ (7,970,085)	$ (2,354,083)	$ (25,170,372)	$ (5,310,814)
Weighted Average Shares Outstanding, basic and diluted	6,324,295	2,564,429	5,910,849	2,560,444
Net loss per share, basic and diluted	$ (1.26)	$ (0.92)	$ (4.26)	$ (2.07)